Genetic factors in systemic sclerosis

por Mayes, Maureen D, Trojanowska, Maria
Publicado 2007

Genetics of scleroderma: implications for personalized medicine?

por Assassi, Shervin, Radstake, Timothy RDJ, Mayes, Maureen D, Martin, Javier
Publicado 2013

Enrichment Strategy for Systemic Sclerosis Clinical Trials Targeting Skin Fibrosis: A Prospective, Multiethnic Cohort Study

por Mihai, Carina, Dobrota, Rucsandra, Assassi, Shervin, Mayes, Maureen D., Distler, Oliver
Publicado 2020

Percutaneous revascularization for the treatment of refractory digital ischemia in systemic sclerosis

por Romero-Karam, Lily A, Honan, Kevin A, Arain, Salman A, Mayes, Maureen D.
Publicado 2022

Characterization of the HLA-DRβ1 third hypervariable region amino acid sequence according to charge and parental inheritance in systemic sclerosis

por Gentil, Coline A., Gammill, Hilary S., Luu, Christine T., Mayes, Maureen D., Furst, Dan E., Nelson, J. Lee
Publicado 2017

Multiomic study of skin, peripheral blood, and serum: is serum proteome a reflection of disease process at the end-organ level in systemic sclerosis?

por Farutin, Victor, Kurtagic, Elma, Pradines, Joël R., Capila, Ishan, Mayes, Maureen D., Wu, Minghua, Manning, Anthony M., Assassi, Shervin
Publicado 2021

Toll-like receptor 3 upregulation by type I interferon in healthy and scleroderma dermal fibroblasts

por Agarwal, Sandeep K, Wu, Minghua, Livingston, Christopher K, Parks, Donald H, Mayes, Maureen D, Arnett, Frank C, Tan, Filemon K
Publicado 2011

Osteopontin in Systemic Sclerosis and its Role in Dermal Fibrosis

por Wu, Minghua, Schneider, Daniel J., Mayes, Maureen D, Assassi, Shervin, Arnett, Frank C., Tan, Filemon K., Blackburn, Michael R., Agarwal, Sandeep K.
Publicado 2012

Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations

por Gourh, Pravitt, Arnett, Frank C, Assassi, Shervin, Tan, Filemon K, Huang, Mei, Diekman, Laura, Mayes, Maureen D, Reveille, John D, Agarwal, Sandeep K
Publicado 2009

Right Bundle Branch Block: A Predictor of Mortality in Early Systemic Sclerosis

por Draeger, Hilda T., Assassi, Shervin, Sharif, Roozbeh, Gonzalez, Emilio B., Harper, Brock E., Arnett, Frank C., Manzoor, Ameena, Lange, Richard A., Mayes, Maureen D.
Publicado 2013

Correction: Right Bundle Branch Block: A Predictor of Mortality in Early Systemic Sclerosis

por Draeger, Hilda T., Assassi, Shervin, Sharif, Roozbeh, Gonzalez, Emilio B., Harper, Brock E., Arnett, Frank C., Manzoor, Ameena, Lange, Richard A., Mayes, Maureen D.
Publicado 2014

Effect of Nintedanib on Lung Function in Patients With Systemic Sclerosis−Associated Interstitial Lung Disease: Further Analyses of a Randomized, Double‐Blind, Placebo‐Controlled T...

por Maher, Toby M., Mayes, Maureen D., Kreuter, Michael, Volkmann, Elizabeth R., Aringer, Martin, Castellvi, Ivan, Cutolo, Maurizio, Stock, Christian, Schoof, Nils, Alves, Margarida, Raghu, Ganesh
Publicado 2021

Continued treatment with nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from SENSCIS-ON

por Allanore, Yannick, Vonk, Madelon C, Distler, Oliver, Azuma, Arata, Mayes, Maureen D, Gahlemann, Martina, James, Alexandra, Kohlbrenner, Veronika, Alves, Margarida, Khanna, Dinesh, Highland, Kristin B
Publicado 2022

Predictors of Fatigue Severity in Early Systemic Sclerosis: A Prospective Longitudinal Study of the GENISOS Cohort

por Assassi, Shervin, Leyva, Astrud L., Mayes, Maureen D., Sharif, Roozbeh, Nair, Deepthi K., Fischbach, Michael, Nguyen, Ngan, Reveille, John D., Gonzalez, Emilio B., McNearney, Terry A.
Publicado 2011

Association of TNFSF4 (OX40L) polymorphisms with susceptibility to systemic sclerosis

por Gourh, Pravitt, Arnett, Frank C, Tan, Filemon K, Assassi, Shervin, Divecha, Dipal, Paz, Gene, McNearney, Terry, Draeger, Hilda, Reveille, John D, Mayes, Maureen D, Agarwal, Sandeep K
Publicado 2010

The Effect of Anti‐Scl‐70 Antibody Determination Method on Its Predictive Significance for Interstitial Lung Disease Progression in Systemic Sclerosis

por Jandali, Bochra, Salazar, Gloria A., Hudson, Marie, Fritzler, Marvin J., Lyons, Marka A., Estrada‐Y‐Martin, Rosa M., Charles, Julio, Terracina, Katherine A., Mayes, Maureen D., Assassi, Shervin
Publicado 2022

Contribution of HLA and KIR Alleles to Systemic Sclerosis Susceptibility and Immunological and Clinical Disease Subtypes

por Hanson, Aimee L., Sahhar, Joanne, Ngian, Gene-Siew, Roddy, Janet, Walker, Jennifer, Stevens, Wendy, Nikpour, Mandana, Assassi, Shervin, Proudman, Susanna, Mayes, Maureen D., Kenna, Tony J., Brown, Matthew A.
Publicado 2022

Association of HLA-DPB1 with Scleroderma and Its Clinical Features in Chinese Population

por Wang, Jiucun, Guo, Xinjian, Yi, Lin, Guo, Gang, Tu, Wenzhen, Wu, Wenyu, Yang, Li, Xiao, Rong, Li, Yuan, Chu, Haiyan, He, Dongyi, Jin, Li, Mayes, Maureen D., Zou, Hejian, Zhou, Xiaodong
Publicado 2014

A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease

por González-Serna, David, Ochoa, Eguzkine, López-Isac, Elena, Julià, Antonio, Degenhardt, Frauke, Ortego-Centeno, Norberto, Radstake, Timothy R. D. J., Franke, Andre, Marsal, Sara, Mayes, Maureen D., Martín, Javier, Márquez, Ana
Publicado 2020

Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, Africa...

por Arnett, Frank C, Gourh, Pravitt, Shete, Sanjay, Ahn, Chul W, Honey, Robert E, Agarwal, Sandeep K, Tan, Filemon K, McNearney, Terry, Fischbach, Michael, Fritzler, Marvin J, Mayes, Maureen D, Reveille, John D
Publicado 2010